![](/img/cover-not-exists.png)
968PPRO-002, a phase Ib dose-escalation study of NUC-1031 with carboplatin for recurrent ovarian cancer
Blagden, S.P., Sukumaran, A., Spiers, L., Woodcock, V.K., Lipplaa, A., Nicum, S., Gnanaranjan, C., Harrison, D.J., Ghazaly, E.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx372.039
Date:
September, 2017
File:
PDF, 82 KB
english, 2017